Skip to content

Myocarditis Prospective Registry Study

Myocarditis Registry Study in Fuwai Hospital

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091653
Enrollment
Unknown
Registered
2024-10-31
Start date
2022-10-05
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocarditis

Interventions

Observation Group:NA

Sponsors

Fuwai Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age = 16 years, no restriction on gender; 2.a. Diagnosed myocarditis patients: includes patients with myocarditis confirmed by myocardial biopsy pathology or histological diagnosis post-heart transplantation, or those with positive myocardial necrosis markers (troponin or creatine kinase-MB) meeting the cardiac MRI diagnostic criteria for myocarditis (Lake Louise criteria, see appendix); b. Clinically diagnosed myocarditis patients: diagnosis criteria refer to the clinical suspected myocarditis diagnostic criteria released by the 2013 ESC guidelines. 3.Signed informed consent form.

Exclusion criteria

Exclusion criteria: Refusal to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Complex clinical phenotype of myocarditis;

Secondary

MeasureTime frame
All-cause mortality;Cardiovascular Death;Major Adverse Cardiovascular Events (MACE);

Countries

CHINA

Contacts

Public ContactYanmin Yang

Fuwai Hospital, Chinese Academy of Medical Sciences

yymfuwai@163.com+86 10 8832 2870

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026